Takeda, CCFA launch IBD awareness initiative, Antibe Therapeutics names Yung Wu to board & more — 4 GI company key notes

Here are four recent news updates on key gastroenterology and endoscopy companies.

Advertisement

Takeda Pharmaceutical, in partnership with the Crohn’s & Colitis Foundation of America, launched IBD Unmasked, a global awareness initiative.

Antibe Therapeutics named Yung Wu to its board of directors and completed enrollment for its phase 2 clinical trial.

SpectraScience signed a distribution agreement with Advanced Medical German in Kuwait.

JP Morgan initiated coverage on EndoChoice’s stock.

More articles on GI/endoscopy:
Surveillance endoscopy improves esophageal cancer outcomes in Barrett’s esophagus patients: 3 insights
Small bowel resection inpatient costs total $28.5k & 7 more statistics
Dr. Maxime Mahe wins 2016 AGA-Athena Troxel Blackburn Award: 4 notes

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.